Inspire 1 and Inspire 2 have taken a long time to complete. We are at 19 of 20 patients in Inspire 2. The patents to protect our intellectual property must now have a limited time left until expiration. Perhaps the new addition of stem cells and nerve growth factors in future trials would extend patent protection for a much longer time. Are we filling for new patents?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.